Skip to main content

Table 2 Lifetime expected cost per TDT patient at 2018/2019 prices from a societal perspective

From: Economic burden in the management of transfusion-dependent thalassaemia patients in Malaysia from a societal perspective

Total cost

Item

US Dollar, USD ($)

Malaysia Ringgit,(MYR)

Proportion of total (%)

TC2

ICT drug

345,251.68

1,405,174.32

56.9

Blood transfusion

79,407.41

323,188.15

13.1

Routine laboratory and instrumental monitoring test

49,984.71

203,437.75

8.2

IOL Complications

48,838.38

198,772.20

8.1

DFO administration

37,725.72

153,543.67

6.2

TC3

45,457.57

185,012.31

7.5

TC1 (TDT patient lifetime cost)

606,665.46

2,469,128.41

100.0